BAFNAPH.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:47):

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets...

Stats
Šios dienos apimtis	1 496.00
Vidutinė apimtis	6 625.00
Rinkos kapitalizacija	2.03B
EPS	INR0 ( 2024-02-11 )
Kita pelno data	( INR0 ) 2024-05-21
Last Dividend	INR0.600 ( 2013-09-19 )
Next Dividend	INR0 ( N/A )
P/E	17.99
ATR14	INR0.617 (0.72%)

Bafna Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
BUTTERFLY.NS	0.955
CLNINDIA.NS	0.942
DIAMONDYD.NS	0.936
BAYERCROP.NS	0.935
FSC.NS	0.934
EASTSILK.NS	0.933
INDIAGLYCO.NS	0.93
TATVA.NS	0.929
ROLTA.NS	0.928
AJRINFRA.NS	0.927

10 Labiausiai neigiamai susiję koreliacijos
HARIOMPIPE.NS	-0.932
CIGNITITEC.NS	-0.921
CONTROLPR.NS	-0.92
SONATSOFTW.NS	-0.918
BECTORFOOD.NS	-0.91
KAYNES.NS	-0.91
CLSEL.NS	-0.91
GEEKAYWIRE.NS	-0.909
TARMAT.NS	-0.904
JMCPROJECT.NS	-0.901

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bafna Pharmaceuticals Finansinės ataskaitos

Annual	2022
Pajamos:	INR1.15B
Bruto pelnas:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Pajamos:	INR1.15B
Bruto pelnas:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Pajamos:	INR851.40M
Bruto pelnas:	INR338.55M (39.76 %)
EPS:	INR2.17

FY	2021
Pajamos:	INR712.18M
Bruto pelnas:	INR257.62M (36.17 %)
EPS:	INR2.46

Financial Reports:

No articles found.

Bafna Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Bafna Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.33%) | Divividend Growth Potential Score: 2.75 - No dividend growth expected in the near future

Information

First Dividend	INR0.600	2013-09-19
Last Dividend	INR0.600	2013-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.600	--
Avg. Dividend % Per Year	0.00%	--
Score	1.02	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	2.75
Div. Directional Score	3.36	--

Next Divdend (Est)
(2024-04-28)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.02

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TRU.NS	Dividend Junior	2023-09-18	Annually	3	0.01%
PIXTRANS.NS	Dividend Junior	2023-07-11	Semi-Annually	3	0.43%
JKLAKSHMI.NS	Dividend Junior	2023-08-11	Annually	18	0.50%
DHRUV.NS	Dividend Junior	2023-09-05	Insufficient data to determine frequency	2	0.15%
SOBHA.NS	Dividend Junior	2023-07-28	Annually	18	0.43%
MMP.NS	Dividend Junior	2023-08-18	Annually	4	0.49%
HDFC.NS	Dividend Junior	2023-05-16	Annually	23	0.85%
BHAGCHEM.NS	Dividend Junior	2023-07-27	Annually	4	0.14%
RAIN.NS	Dividend Junior	2023-05-19	Annually	18	0.39%
KIRLOSBROS.NS	Dividend Junior	2023-07-25	Annually	17	0.99%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0735	1.500	8.53	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.145	1.500	9.50	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.17	1.000	9.20	9.20	[3 - 30]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.44	2.00	7.78	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.305	1.000	8.25	8.25	[0.2 - 0.8]
operatingProfitMarginTTM	0.0782	1.000	-0.436	-0.436	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	18.06	1.000	8.28	0	[1 - 100]
returnOnEquityTTM	0.145	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.777	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0685	1.000	-0.788	0	[0.1 - 0.5]
Total Score				2.75

Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.